These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5030540)

  • 21. Association mechanism of four acetylcholinesterase inhibitors (AChEIs) with human serum albumin: a biochromatographic approach.
    Ibrahim F; André C; Thomassin M; Guillaume YC
    J Pharm Biomed Anal; 2008 Dec; 48(5):1345-50. PubMed ID: 18996666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin.
    O'Reilly RA
    J Clin Invest; 1969 Jan; 48(1):193-202. PubMed ID: 5765021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the myricetin-human serum albumin complex by spectroscopic and molecular modeling approaches.
    Qin C; Xie MX; Liu Y
    Biomacromolecules; 2007 Jul; 8(7):2182-9. PubMed ID: 17559264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of some drugs on the binding of bilirubin and bromsulphalein to serum albumins in vitro].
    Kucerová L; Smejkal V
    Cas Lek Cesk; 1969 Jun; 108(24):737-8. PubMed ID: 5783180
    [No Abstract]   [Full Text] [Related]  

  • 25. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
    Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
    Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interaction of pipolfen and suprastin with human serum albumin depending on the pH of the medium and its calcium ion content].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1983; 46(6):59-63. PubMed ID: 6653761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating noncovalent interactions of rutin-serum albumin by capillary electrophoresis-frontal analysis.
    Lu QH; Ba CD; Chen DY
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):888-91. PubMed ID: 18436413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycated human serum albumin as AGE-carrier protein in enzyme-linked immunosorbent assay.
    Benko B; Turk Z
    Clin Lab; 2008; 54(9-10):331-9. PubMed ID: 19097490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H and 13C NMR study of the molecular interaction mechanism between chloramphenicol and human serum albumin.
    Panov V; Shipanova I; Michtchenko A; Shabunin I; Shimanovskii N; Sibeldina L; Sergeev P
    Biochem Mol Biol Int; 1995 Feb; 35(2):457-60. PubMed ID: 7663402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
    Dubois N; Lapicque F; Abiteboul M; Netter P
    Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
    Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
    Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human serum albumin adsorption on hydrogel contact lenses in vitro.
    Garrett Q; Milthorpe BK
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2594-602. PubMed ID: 8977473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin.
    Yang F; Bian C; Zhu L; Zhao G; Huang Z; Huang M
    J Struct Biol; 2007 Feb; 157(2):348-55. PubMed ID: 17067818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex formation between macromolecules and drugs. 8. Binding of saccharine, N-methyl saccharine, and the diuretic drugs hydroflumethiazide and bendroflumethiazide to human serum albumin.
    Agren A; Bäck T
    Acta Pharm Suec; 1973 Jun; 10(3):223-8. PubMed ID: 4729699
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of pH on aggregation and protein binding of barbituric acid and amylobarbitone.
    Mikikits W; Skinner A; Spector RG; Watts DC
    Br J Pharmacol; 1971 Jan; 41(1):76-83. PubMed ID: 5547763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protein binding of barbiturates on their rate of removal during peritoneal dialysis.
    Campion DS; North JD
    J Lab Clin Med; 1965 Oct; 66(4):549-63. PubMed ID: 5843083
    [No Abstract]   [Full Text] [Related]  

  • 37. The binding of salicylate to human serum.
    Moran CJ; Walker WH
    Biochem Pharmacol; 1968 Jan; 17(1):153-6. PubMed ID: 5638550
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of sulfonylureas to serum proteins.
    Judis J
    J Pharm Sci; 1972 Jan; 61(1):89-93. PubMed ID: 5058652
    [No Abstract]   [Full Text] [Related]  

  • 39. Binding of drugs to plasma proteins of swine during the perinatal period.
    Short CR; Tumbleson ME
    Toxicol Appl Pharmacol; 1973 Apr; 24(4):612-24. PubMed ID: 4713484
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of action of phenolic disinfectants. VII. Factors affecting binding of phenol derivatives to Micrococcus lysodeikticus cells.
    Judis J
    J Pharm Sci; 1966 Aug; 55(8):803-7. PubMed ID: 4166678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.